Contribution and Satisfaction of Indebtedness Agreement Sample Contracts

CONTRIBUTION AND SATISFACTION OF INDEBTEDNESS AGREEMENT

Contribution and Satisfaction of Indebtedness Agreement • September 14th, 2022 • Sorrento Therapeutics, Inc. • Biological products, (no disgnostic substances) • California

• Contract Type
  Contribution and Satisfaction of Indebtedness Agreement
• Filed
  September 14th, 2022
• Company
  Sorrento Therapeutics, Inc.
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  California

This CONTRIBUTION AND SATISFACTION OF INDEBTEDNESS AGREEMENT (this “Agreement”), entered into as of September 12, 2022 (the “Agreement Date”), is by and among SORRENTO THERAPEUTICS, INC., a Delaware corporation (the “Sorrento”), SCILEX HOLDING COMPANY, a direct wholly owned subsidiary of Sorrento (“Scilex”), and SCILEX PHARMACEUTICALS, INC., an indirect wholly owned subsidiary of Sorrento and direct wholly owned subsidiary of Scilex (“Scilex Pharma”).

CONTRIBUTION AND SATISFACTION OF INDEBTEDNESS AGREEMENT

Contribution and Satisfaction of Indebtedness Agreement • September 13th, 2022 • Vickers Vantage Corp. I • Biological products, (no disgnostic substances) • California

• Contract Type
  Contribution and Satisfaction of Indebtedness Agreement
• Filed
  September 13th, 2022
• Company
  Vickers Vantage Corp. I
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  California

This CONTRIBUTION AND SATISFACTION OF INDEBTEDNESS AGREEMENT (this “Agreement”), entered into as of September 12, 2022 (the “Agreement Date”), is by and among SORRENTO THERAPEUTICS, INC., a Delaware corporation (the “Sorrento”), SCILEX HOLDING COMPANY, a direct wholly owned subsidiary of Sorrento (“Scilex”), and SCILEX PHARMACEUTICALS, INC., an indirect wholly owned subsidiary of Sorrento and direct wholly owned subsidiary of Scilex (“Scilex Pharma”).